# Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion

> **NCT03028038** · PHASE1 · COMPLETED · sponsor: **Damascus University** · enrollment: 16 (actual)

## Conditions studied

- Bone Resorption

## Interventions

- **DRUG:** Platelet Rich Plasma
- **DRUG:** No Platelet Rich Plasma

## Key facts

- **NCT ID:** NCT03028038
- **Lead sponsor:** Damascus University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-05
- **Final completion:** 2018-07-15
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03028038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03028038, "Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03028038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*